157 related articles for article (PubMed ID: 10484087)
21. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
Iinuma H; Okinaga K
J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
[TBL] [Abstract][Full Text] [Related]
22. [Antibody response to pneumococcal polysaccharide antigens following splenectomy and replantation of autologous splenic tissue].
Sklenar I; Dürig M; Lydick E; Erb P; Harder F
Aktuelle Probl Chir Orthop; 1985; 30():107-12. PubMed ID: 2867694
[No Abstract] [Full Text] [Related]
23. Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.
Leemans R; Manson W; Snijder JA; Smit JW; Klasen HJ; The TH; Timens W
Ann Surg; 1999 Feb; 229(2):279-85. PubMed ID: 10024111
[TBL] [Abstract][Full Text] [Related]
24. Pneumococcal vaccination for splenectomized patients with thalassemia major in Indonesia.
Sari TT; Akib AAP; Gatot D; Roswita Harahap A; Bardosono S; Hadinegoro SRS
Vaccine; 2017 Aug; 35(35 Pt B):4583-4586. PubMed ID: 28712490
[TBL] [Abstract][Full Text] [Related]
25. Antibody response to an autogenous vaccine and serologic profile for Streptococcus suis capsular type 1/2.
Lapointe L; D'Allaire S; Lebrun A; Lacouture S; Gottschalk M
Can J Vet Res; 2002 Jan; 66(1):8-14. PubMed ID: 11858652
[TBL] [Abstract][Full Text] [Related]
26. Humoral immune response to pneumococcal vaccination. Prevention of infections with Streptococcus pneumoniae by immunization.
Konradsen HB
APMIS Suppl; 1996; 60():1-28. PubMed ID: 8764926
[No Abstract] [Full Text] [Related]
27. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.
Musher DM; Ceasar H; Kojic EM; Musher BL; Gathe JC; Romero-Steiner S; White AC
J Infect Dis; 2005 Apr; 191(7):1063-7. PubMed ID: 15747240
[TBL] [Abstract][Full Text] [Related]
28. Effect of cirrhosis on the production and efficacy of pneumococcal capsular antibody in a rat model.
Preheim LC; Mellencamp MA; Snitily MU; Gentry MJ
Am Rev Respir Dis; 1992 Oct; 146(4):1054-8. PubMed ID: 1416396
[TBL] [Abstract][Full Text] [Related]
29. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
30. [Factors Influencing Pneumococcal Vaccination-Induced Total IgG, IgG2, and IgA Levels in Vaccinated Splenectomized Patients].
Gazi U; Derici MK; Karasartova D; Güreser AS; Şahiner İT; Dolapçı M; Taylan Özkan A
Mikrobiyol Bul; 2022 Jan; 56(1):103-113. PubMed ID: 35088964
[TBL] [Abstract][Full Text] [Related]
31. The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria.
Holdsworth RJ; McKenzie H; Parratt D; Irving AD; Cuschieri A
Int J Exp Pathol; 1990 Dec; 71(6):835-43. PubMed ID: 2278827
[TBL] [Abstract][Full Text] [Related]
32. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
[TBL] [Abstract][Full Text] [Related]
33. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
34. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
[TBL] [Abstract][Full Text] [Related]
35. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
[TBL] [Abstract][Full Text] [Related]
36. Immune function of the upper splenic remnant supplied by short gastric vessels.
Gürleyik E; Gürleyik G; Ozkutlu D
Eur J Surg; 1999 Sep; 165(9):897-902. PubMed ID: 10533768
[TBL] [Abstract][Full Text] [Related]
37. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Aaberge IS; Heier HE
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):363-9. PubMed ID: 6524388
[TBL] [Abstract][Full Text] [Related]
38. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
39. A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons.
Chang Q; Abadi J; Alpert P; Pirofski L
J Infect Dis; 2000 Apr; 181(4):1313-21. PubMed ID: 10762563
[TBL] [Abstract][Full Text] [Related]
40. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
